Trial intelligence / Profile preview

BTDS vs co-codamol for physical activity in older adults with knee osteoarthritis

2007-002357-23Phase 4Completed

Sponsor
Newcastle Hospitals NHS Foundation Trust
Start
Jan 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of buprenorphine in knee osteoarthritis (OA) (2 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Mean total ambulatory energy expenditure over 24 hours. Started Jan 2009; status: completed.

02

Drugs

buprenorphine
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2007-002357-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002357-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call